Last Updated: November 16, 2026

CLINICAL TRIALS PROFILE FOR ASP8062

« Back to Dashboard


Clinical Trials for ASP8062

Trial ID Title Status Sponsor Phase Summary
NCT03092726 ↗ A Study to Assess the Analgesic Efficacy and Safety of ASP8062 in Subjects With Fibromyalgia Completed Astellas Pharma Global Development, Inc. Phase 2 The purpose of this study was to assess analgesic efficacy of ASP8062 relative to placebo as well as the safety and tolerability. This study also assessed the treatment differences in physical function as well the improvements in overall subject status (e.g., fibromyalgia symptoms, global functioning) of ASP8062 relative to placebo.
NCT03183739 ↗ Study to Evaluate the Safety and Tolerability of ASP8062 in Healthy Japanese Male and Female Subjects Completed Astellas Pharma Inc Phase 1 The purpose of this study is to evaluate the safety and tolerability and evaluate pharmacokinetics of single and multiple ascending oral doses of ASP8062 in nonelderly Japanese male and female subjects.
NCT04003402 ↗ A Study to Assess Potential Interaction Between ASP8062 and Alcohol in Healthy Adult Subjects Completed Astellas Pharma Global Development, Inc. Phase 1 The purpose of this study is to assess the potential for pharmacokinetic (PK) and pharmacodynamics (PD) interactions between ASP8062 and alcohol. This study will also assess safety and tolerability of a single dose of ASP8062 with or without alcohol.
>Trial ID >Title >Status >Phase >Summary

Clinical Trial Conditions for ASP8062

Condition Name

Condition Name
Intervention Trials
Opioid Use Disorder 3
Healthy Volunteers 2
Alcohol Drinking 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH
Intervention Trials
Opioid-Related Disorders 3
Disease 3
Substance-Related Disorders 3
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for ASP8062

Trials by Country

Trials by Country
Location Trials
United States 25
Japan 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State
Location Trials
Kansas 2
Rhode Island 2
California 2
Maryland 1
Wisconsin 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for ASP8062

Clinical Trial Phase

Clinical Trial Phase
Clinical Trial Phase Trials
Phase 2 3
Phase 1 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status
Clinical Trial Phase Trials
Completed 5
Not yet recruiting 1
Recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for ASP8062

Sponsor Name

Sponsor Name
Sponsor Trials
Astellas Pharma Global Development, Inc. 5
Astellas Pharma Inc 2
National Institute on Drug Abuse (NIDA) 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type
Sponsor Trials
Industry 7
NIH 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.